Lessons from gefitinib-induced interstitial lung disease in Japan: Problems in approval, pharmacovigilance, and regulatory decision-making procedures

類似資料

• Lessons from gefitinib-induced interstitial lung disease in Japan: Problems in approval, pharmacovigilance, and regulatory decision-making procedures
  著者:: Tsutomu Nishimura, 等
  出版事項: (2006)
• Interstitial lung disease in gefitinib-treated Japanese patients with non-small cell lung cancer – a retrospective analysis: JMTO LC03-02
  著者:: Nakagawa, Masatsugu, 等
  出版事項: (2009)
• Association of geomagnetic disturbances and suicides in Japan, 1999–2010
  著者:: Tada, Harue, 等
  出版事項: (2013)
• Correlation between the Lunar Phase and Tail-Lifting Behavior of Lizards (Pogona vitticeps) Exposed to an Extremely Low-Frequency Electromagnetic Field
  著者:: Nishimura, Tsutomu, 等
  出版事項: (2019)
• Risk factors for lower limb lymphedema after lymph node dissection in patients with ovarian and uterine carcinoma
  著者:: Fukushima Masanori, 等
  出版事項: (2009-02-01)